- Home
- ATHA vs PWM Comparison
ATHA vs PWM Comparison
Compare ATHA & PWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- PWM
- Stock Information
- Founded
- ATHA 2011
- PWM 2018
- Country
- ATHA United States
- PWM Hong Kong
- Employees
- ATHA N/A
- PWM N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- PWM
- Sector
- ATHA Health Care
- PWM
- Exchange
- ATHA Nasdaq
- PWM Nasdaq
- Market Cap
- ATHA 14.8M
- PWM 12.4M
- IPO Year
- ATHA 2020
- PWM 2023
- Fundamental
- Price
- ATHA $0.36
- PWM $0.54
- Analyst Decision
- ATHA Hold
- PWM
- Analyst Count
- ATHA 3
- PWM 0
- Target Price
- ATHA $0.50
- PWM N/A
- AVG Volume (30 Days)
- ATHA 149.8K
- PWM 1.2M
- Earning Date
- ATHA 11-06-2025
- PWM 02-13-2026
- Dividend Yield
- ATHA N/A
- PWM N/A
- EPS Growth
- ATHA N/A
- PWM N/A
- EPS
- ATHA N/A
- PWM N/A
- Revenue
- ATHA N/A
- PWM $639,912.00
- Revenue This Year
- ATHA N/A
- PWM N/A
- Revenue Next Year
- ATHA N/A
- PWM N/A
- P/E Ratio
- ATHA N/A
- PWM N/A
- Revenue Growth
- ATHA N/A
- PWM 83.60
- 52 Week Low
- ATHA $0.22
- PWM $0.31
- 52 Week High
- ATHA $0.83
- PWM $2.70
- Technical
- Relative Strength Index (RSI)
- ATHA 36.59
- PWM 56.13
- Support Level
- ATHA $0.35
- PWM $0.51
- Resistance Level
- ATHA $0.40
- PWM $0.60
- Average True Range (ATR)
- ATHA 0.02
- PWM 0.05
- MACD
- ATHA -0.00
- PWM -0.00
- Stochastic Oscillator
- ATHA 11.86
- PWM 30.34
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About PWM Prestige Wealth Inc.
Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.